magnesium pidolate
magnesium, bis(5-oxo-L-prolinato-N1,O2)-, (T-4)-
Identification
| Name | magnesium pidolate |
| IUPAC | magnesium 5-oxopyrrolidine-2-carboxylic acid |
| CAS Number | 62003-27-4 |
| EINECS | 263-365-7 |
| FDA UNII | V5PC588N7G |
| Molecular Formula | C5 H7 Mg N O3 +2 |
| Molecular Weight | 153.42039000 |
| MDL Number | MFCD00792303 |
Regulatory
Physical Properties
| Assay | 95.00 to 100.00 |
| Food Chemicals Codex Listed | No |
| Boiling Point | 453.10 °C. @ 760.00 mm Hg (est) |
| Vapor Pressure | 0.000000 mmHg @ 25.00 °C. (est) |
| Flash Point | 442.00 °F. TCC ( 227.80 °C. ) (est) |
| logP (o/w) | -2.387 (est) |
No sensory data available
Safety Information
| Preferred SDS | View |
| Oral/Parenteral Toxicity | Not determined |
| Dermal Toxicity | Not determined |
| Inhalation Toxicity | Not determined |
GHS Classification
['GHS Classification in accordance with 29 CFR 1910 (OSHA HCS)', 'GHS Label elements, including precautionary statements']
Safety in Use
| Category | nutrient supplements |
| Recommendation for magnesium pidolate usage levels up to | not for fragrance use. |
| Recommendation for magnesium pidolate flavor usage levels up to | not for flavor use. |
American International Chemical, Inc.
Consistent sources
North American supplier for globally sourced ingredients.
Potential Uses
Natural Occurrence
Synonyms
MAG2
magnesium 5-oxopyrrolidine-2-carboxylic acid
magnesium, bis(5-oxo-L-prolinato-N1,O2)-, (T-4)-
bis(5-oxo-L-
prolinato-N1,O2)magnesium
bis(5-oxo-laevo-
prolinato-N1,O2)magnesium
PubMed:
Late Outcome of a Randomized Study on Oral Magnesium for Premature Complexes.
PubMed:
Effects of magnesium supplements on blood pressure, endothelial function and metabolic parameters in healthy young men with a family history of metabolic syndrome.
PubMed:
Effects of supplementation with different Mg salts in cells: is there a clue?
PubMed:
Promising therapies in sickle cell disease.
PubMed:
Phase I study of magnesium pidolate in combination with hydroxycarbamide for children with sickle cell anaemia.
PubMed:
Magnesium as a preventive treatment for paediatric episodic tension-type headache: results at 1-year follow-up.
PubMed:
[Clinical trials of new therapeutic pharmacology for sickle cell disease].
PubMed:
Magnesium as a treatment for paediatric tension-type headache: a clinical replication series.
PubMed:
Intracellular Mg2+ diffusion within isolated rat skeletal muscle fibers.
PubMed:
Oral magnesium pidolate: effects of long-term administration in patients with sickle cell disease.
PubMed:
Magnesium pidolate and magnesium aspartate effects on human amniotic membrane ionic permeability in vitro.
PubMed:
The effect of dietary magnesium supplementation on the cellular abnormalities of erythrocytes in patients with beta thalassemia intermedia.
PubMed:
Visual evoked potentials and serum magnesium levels in juvenile migraine patients.
PubMed:
Reversible model of magnesium depletion induced by systemic kainic acid injection in magnesium-deficient rats: I--Comparative study of various magnesium salts.
PubMed:
Inhibition of mouse-killing behaviour in magnesium-deficient rats: effect of pharmacological doses of magnesium pidolate, magnesium aspartate, magnesium lactate, magnesium gluconate and magnesium chloride.
PubMed:
Effects of oral magnesium supplementation on plasma lipid concentrations in patients with non-insulin-dependent diabetes mellitus.
PubMed:
[Magnesium in the prophylaxis of primary headache and other periodic disorders in children].
PubMed:
Intravenous and oral magnesium supplementations in the prophylaxis of cisplatin-induced hypomagnesemia. Results of a controlled trial.
PubMed:
Long-term magnesium supplementation in essential hypertension.
PubMed:
Effectiveness of magnesium pidolate in the prophylactic treatment of primary dysmenorrhea.
PubMed:
[Effects of magnesium pidolate on cardiovascular hemodynamics].
PubMed:
Magnesium pidolate in the treatment of seasonal allergic rhinitis. Preliminary data.